These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1381080)

  • 1. Driving restrictions advised by midwestern cardiologists implanting cardioverter defibrillators: present practices, criteria utilized, and compatibility with existing state laws.
    DiCarlo LA; Winston SA; Honoway S; Reed P
    Pacing Clin Electrophysiol; 1992 Aug; 15(8):1131-6. PubMed ID: 1381080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Driving restrictions for arrhythmia patients--with special reference to the implantable cardioverter/defibrillator].
    Lüderitz B; Jung W
    Z Kardiol; 1996; 85 Suppl 6():115-21. PubMed ID: 9064955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life and driving in recipients of the implantable cardioverter-defibrillator.
    Jung W; Lüderitz B
    Am J Cardiol; 1996 Sep; 78(5A):51-6. PubMed ID: 8820836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When should patients with lethal ventricular arrhythmia resume driving? An analysis of state regulations and physician practices.
    Strickberger SA; Cantillon CO; Friedman PL
    Ann Intern Med; 1991 Oct; 115(7):560-3. PubMed ID: 1883126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Driving following defibrillator implantation: development and pilot results from a nationwide questionnaire.
    Bjerre J; Rosenkranz SH; Christensen AM; Schou M; Jøns C; Gislason G; Ruwald AC
    BMC Cardiovasc Disord; 2018 Nov; 18(1):212. PubMed ID: 30458722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Driving of a motor vehicle after implantation of a cardioverter-defibrillator in malignant heart rhythm disorders. Criteria for the medical assessment of driving fitness in Europe].
    Lüderitz B; Jung W
    Dtsch Med Wochenschr; 1996 Feb; 121(5):119-23. PubMed ID: 8717193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor vehicle accidents in patients with an implantable cardioverter-defibrillator.
    Curtis AB; Conti JB; Tucker KJ; Kubilis PS; Reilly RE; Woodard DA
    J Am Coll Cardiol; 1995 Jul; 26(1):180-4. PubMed ID: 7797749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline factors predicting early resumption of driving after life-threatening arrhythmias in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.
    Hickey K; Curtis AB; Lancaster S; Larsen G; Warwick D; McAnulty J; Mitchell LB
    Am Heart J; 2001 Jul; 142(1):99-104. PubMed ID: 11431664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
    Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
    Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study.
    Albert CM; Rosenthal L; Calkins H; Steinberg JS; Ruskin JN; Wang P; Muller JE; Mittleman MA;
    J Am Coll Cardiol; 2007 Dec; 50(23):2233-40. PubMed ID: 18061071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias.
    Tchou PJ; Kadri N; Anderson J; Caceres JA; Jazayeri M; Akhtar M
    Ann Intern Med; 1988 Oct; 109(7):529-34. PubMed ID: 3262325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic automatic implantable cardioverter-defibrillator patches in patients at high risk for postoperative ventricular tachyarrhythmias.
    Manolis AS; Rastegar H; Estes NA
    J Am Coll Cardiol; 1989 May; 13(6):1367-73. PubMed ID: 2784806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of loss of consciousness during automatic implantable cardioverter-defibrillator shocks.
    Kou WH; Calkins H; Lewis RR; Bolling SF; Kirsch MM; Langberg JJ; de Buitleir M; Sousa J; el-Atassi R; Morady F
    Ann Intern Med; 1991 Dec; 115(12):942-5. PubMed ID: 1952491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of ventricular arrhythmias by United States cardiologists: a survey before the Cardiac Arrhythmia Suppression Trial results were available.
    Morganroth J; Bigger JT; Anderson JL
    Am J Cardiol; 1990 Jan; 65(1):40-8. PubMed ID: 1688481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter defibrillators (ICD): successful implantation using a single endocardial lead.
    Johnston RT; Skehan JD; Spyt TJ
    Eur J Cardiothorac Surg; 1992; 6(7):394. PubMed ID: 1497934
    [No Abstract]   [Full Text] [Related]  

  • 17. [Restrictions for ICD patients in daily life].
    Köbe J; Gradaus R; Zumhagen S; Böcker D
    Herz; 2005 Nov; 30(7):625-9. PubMed ID: 16333589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal extracorporeal shock wave lithotripsy performed in patient with implantable cardioverter defibrillator.
    Venditti FJ; Martin D; Long AL; Roth RA
    Pacing Clin Electrophysiol; 1991 Sep; 14(9):1323-5. PubMed ID: 1720523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of malignant ventricular arrhythmias using antitachycardia devices.
    McCowan RJ; Sampath R; Lee KC; Rashid H; Cafoncelli AR; Khan ZM; Malik FS; Chapman JL; Figueroa E; Freund PE
    W V Med J; 1991 Sep; 87(9):395-9. PubMed ID: 1949755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.